<p>Scott Tagawa discusses his ESMO Presidential presentation on Lu-PSMA-617 in patients with mHSPC</p>

Episode 452: ESMO 2025 - DV+ toripalimab in bladder cancer

Broadcasting the latest developments in GU cancer

Hosted by Brian Rini and Tom Powles 

Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London